Back to results
US 2025/0017862 A1Published application
Solid dispersions comprising a sgc stimulator
AssigneeCyclerion Therapeutics, Inc.
InventorsCraig Antony Dunbar, Vasu Sethuraman, Ahmad Hashash
Life of this patent
Estimating the term…
Abstract
The present invention relates to solid dispersions of amorphous 1,1,1,3,3,3-hexafluoro-2-(((5-fluoro-2-(1-(2-fluorobenzyl)-5-(isoxazol-3-yl)-1H-pyrazol-3-yl)pyrimidin-4-yl)amino)methyl)propan-2-ol (Compound I) or a pharmaceutically acceptable salt thereof. It also relates to pharmaceutical compositions and pharmaceutical oral dosage unit forms comprising them, and their uses thereof.
Claims50
A solid dispersion of amorphous 1,1,1,3,3,3-hexafluoro-2-(((5-fluoro-2-(1-(2-fluorobenzyl)-5-(isoxazol-3-yl)-1H-pyrazol-3-yl)pyrimidin-4-yl)amino)methyl)propan-2-ol (Compound I).
Dependencies are inferred from the claim text.